Find clinical trials for Non-Hodgkin Lymphoma in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma

B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma

B-Cell Chronic Lymphocytic Leukemia

Mantle-Cell Lymphoma

Cancer

Non-Hodgkin Lymphoma trials near Roma, Lazio, ITA:

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)

to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...

Active, not recruiting

Non-Hodgkin Lymphoma

Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)

Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy

Phase 3

Novartis

Roma, RM, Italy and 71 other locations

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...

Enrolling

Hodgkin Disease

Lymphoma, Non-Hodgkin

Drug: Relatlimab

Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)

Roma, Italy and 75 other locations

A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma (iMATRIX GLO)

ifosfamide, carboplatin, and etoposide (R-ICE) in pediatric and young adult participants with relapsed and refractory (R/R) mature B-cell non...

Enrolling

Mature B-Cell Non-Hodgkin Lymphoma

Drug: Ifosfamide

Drug: Rituximab

Phase 1, Phase 2

Roche

Rome, Lazio, Italy and 26 other locations

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL (SOUNDTRACK-B)

monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least tw...

Enrolling

Large B-Cell Lymphoma (LBCL)

B-cell Non-Hodgkin Lymphoma

Drug: Surovatamig

Phase 2

AstraZeneca

Roma, Italy and 89 other locations

Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)

lymphoblastic leukemia (ALL) or relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (NHL).As of October 2022, no furt...

Active, not recruiting

Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Drug: Cyclophosphamide

Biological: Brexucabtagene Autoleucel (KTE-X19)

Phase 1, Phase 2

Gilead Sciences

Rome, Italy and 29 other locations

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

The most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell lymphoma...

Active, not recruiting

Non-hodgkin Lymphoma

Drug: Epcoritamab

Phase 1

Genmab

Rome, Roma, Italy and 40 other locations

A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation (MANGROVE)

the efficacy and safety of zanubrutinib plus rituximab versus bendamustine plus rituximab in previously untreated participants with mantle cell lymphoma...

Active, not recruiting

Mantle Cell Lymphoma; Non-Hodgkin Lymphoma

Drug: rituximab

Drug: zanubrutinib

Phase 3

BeiGene

Roma, Italy and 180 other locations

Locations recently updated

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

of chronic lymphocytic leukemia (CLL)/ small lymphocytic lymphoma (SLL), Richter's transformation, marginal zone lymphoma (MZL), ma...

Enrolling

Non-Hodgkins Lymphoma

Waldenstroms Macroglobulinaemia

Drug: Nemtabrutinib

Phase 2

Merck Sharp & Dohme (MSD)

Roma, Italy and 121 other locations

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)

Study consists of two main parts to explore BGB-16673 recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy dose escalation...

Enrolling

Marginal Zone Lymphoma

Mantle Cell Lymphoma

Drug: BGB-16673

Phase 1, Phase 2

BeOne Medicines

Roma, Italy and 114 other locations

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...

Active, not recruiting

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals

Rome, Italy and 146 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Non-Hodgkin Lymphoma in .css-epvm6{white-space:nowrap;}Roma, Lazio

Related conditions:

Non-Hodgkin Lymphoma trials near Roma, Lazio, ITA:

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma (iMATRIX GLO)

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL (SOUNDTRACK-B)

Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4)

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation (MANGROVE)

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

Find clinical trials for Non-Hodgkin Lymphoma in Roma, Lazio